- Home
- IPHA vs IDN Comparison
IPHA vs IDN Comparison
Compare IPHA & IDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IPHA | IDN |
|---|---|---|
| Founded | 1999 | 1994 |
| Country | France | United States |
| Employees | 174 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 119.1M | 103.0M |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | IPHA | IDN |
|---|---|---|
| Price | $1.22 | $5.37 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 3 |
| Target Price | $5.75 | ★ $7.33 |
| AVG Volume (30 Days) | 11.9K | ★ 96.2K |
| Earning Date | 03-26-2026 | 03-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 220.00 |
| EPS | N/A | ★ 0.06 |
| Revenue | N/A | ★ $4,433,454.00 |
| Revenue This Year | $28.31 | $12.21 |
| Revenue Next Year | N/A | $12.44 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 23.21 |
| 52 Week Low | $1.31 | $2.30 |
| 52 Week High | $2.63 | $7.48 |
Technical Indicators
Market Signals| Indicator | IPHA | IDN |
|---|---|---|
| Relative Strength Index (RSI) | 21.88 | 61.49 |
| Support Level | N/A | $5.12 |
| Resistance Level | $1.88 | $5.74 |
| Average True Range (ATR) | 0.08 | 0.27 |
| MACD | -0.04 | 0.08 |
| Stochastic Oscillator | 2.79 | 51.59 |
Price Performance
Historical ComparisonAbout IPHA Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.
About IDN Intellicheck Inc.
Intellicheck Inc is a trusted industry leader in technology solutions that stop identity theft and fraud with real-time identification authentication and age verification. The group delivers on-demand digital and physical identity verification solutions for KYC, AML, fraud prevention, and age verification needs. The products of the company include solutions for preventing identity fraud across any industry delivered via smartphone, tablet, POS integration or other electronic devices.